- Home
- CPHI vs APVO Comparison
CPHI vs APVO Comparison
Compare CPHI & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPHI
- APVO
- Stock Information
- Founded
- CPHI N/A
- APVO 2016
- Country
- CPHI China
- APVO United States
- Employees
- CPHI N/A
- APVO N/A
- Industry
- CPHI Biotechnology: Pharmaceutical Preparations
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- CPHI Health Care
- APVO Health Care
- Exchange
- CPHI Nasdaq
- APVO Nasdaq
- Market Cap
- CPHI 4.2M
- APVO 4.4M
- IPO Year
- CPHI N/A
- APVO N/A
- Fundamental
- Price
- CPHI $0.18
- APVO $4.45
- Analyst Decision
- CPHI
- APVO Strong Buy
- Analyst Count
- CPHI 0
- APVO 1
- Target Price
- CPHI N/A
- APVO $296.00
- AVG Volume (30 Days)
- CPHI 379.7K
- APVO 495.0K
- Earning Date
- CPHI 11-13-2024
- APVO 11-07-2024
- Dividend Yield
- CPHI N/A
- APVO N/A
- EPS Growth
- CPHI N/A
- APVO N/A
- EPS
- CPHI N/A
- APVO N/A
- Revenue
- CPHI $5,544,620.00
- APVO N/A
- Revenue This Year
- CPHI N/A
- APVO N/A
- Revenue Next Year
- CPHI N/A
- APVO N/A
- P/E Ratio
- CPHI N/A
- APVO N/A
- Revenue Growth
- CPHI N/A
- APVO N/A
- 52 Week Low
- CPHI $0.13
- APVO $3.65
- 52 Week High
- CPHI $0.70
- APVO $399.60
- Technical
- Relative Strength Index (RSI)
- CPHI 41.48
- APVO 35.28
- Support Level
- CPHI $0.13
- APVO $4.20
- Resistance Level
- CPHI $0.20
- APVO $4.73
- Average True Range (ATR)
- CPHI 0.03
- APVO 1.69
- MACD
- CPHI -0.00
- APVO -0.45
- Stochastic Oscillator
- CPHI 55.13
- APVO 6.86
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.